Showing results (231-240 of 254) with videos related to
Sort By:
Pageof 26
Bipolar Disorders|August 24, 2017
Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trialE M Tunbridge, M J Attenburrow, A Gardiner, et al.Journal of Intellectual Disability Research : JIDR|December 21, 2018
Vitamin D, bone mineral density and risk of fracture in people with intellectual disabilitiesV Frighi, A Morovat, T M Andrews, et al.Journal of Affective Disorders|December 1, 1993
State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatmentG M Goodwin, M P Austin, N Dougall, et al.Psychological Medicine|August 31, 2016
Associations between mood instability and emotional processing in a large cohort of bipolar patientsA C Bilderbeck, Z E Reed, H C McMahon, et al.The British Journal of Psychiatry : the Journal of Mental Science|August 1, 1993
A single photon emission computerised tomography study of regional brain function in elderly patients with major depression and with Alzheimer-type dementiaS M Curran, C M Murray, M Van Beck, et al.Cephalalgia : an International Journal of Headache|May 28, 1998
Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with auraA D Ogilvie, M B Russell, P Dhall, et al.Biological Psychiatry|April 1, 1993
Single-photon emission computed tomography with 99mTc-exametazime in unmedicated schizophrenic patientsK P Ebmeier, D H Blackwood, C Murray, et al.Journal of Neurochemistry|March 31, 1999
Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3' untranslated region of the human serotonin transporter geneS Battersby, A D Ogilvie, D H Blackwood, et al.Journal of Affective Disorders|December 1, 1993
The elevation of plasma beta-endorphin levels in major depressionG M Goodwin, M P Austin, S M Curran, et al.Psychological Medicine|January 29, 2014
Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levelsA R Rosa, N Singh, E Whitaker, et al.Pageof 26